USD 67.19
(-2.38%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 417.4 Million USD | 11911.51% |
2022 | 3.47 Million USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 2.93 Million USD | 157.09% |
2019 | 1.14 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 523.51 Million USD | 0.0% |
2024 Q2 | 87.7 Million USD | 0.0% |
2024 Q1 | 89.8 Million USD | -100.0% |
2023 Q3 | 509.65 Million USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | 417.4 Million USD | 11911.51% |
2023 Q1 | - USD | -100.0% |
2023 Q4 | 417.4 Million USD | -18.1% |
2022 Q3 | - USD | 0.0% |
2022 Q4 | 3.47 Million USD | 0.0% |
2022 FY | 3.47 Million USD | 0.0% |
2022 Q1 | - USD | 100.0% |
2022 Q2 | - USD | 0.0% |
2021 Q3 | 3.29 Million USD | -13.33% |
2021 Q4 | -4.31 Million USD | -230.85% |
2021 Q2 | 3.8 Million USD | 10.13% |
2021 FY | - USD | -100.0% |
2021 Q1 | 3.45 Million USD | 155.69% |
2020 Q1 | 1.77 Million USD | 129.47% |
2020 Q2 | 2.32 Million USD | 30.93% |
2020 Q3 | 2.61 Million USD | 12.31% |
2020 Q4 | -6.2 Million USD | -337.62% |
2020 FY | 2.93 Million USD | 157.09% |
2019 Q2 | 740 Thousand USD | -7.85% |
2019 Q1 | 803 Thousand USD | 109.9% |
2019 Q3 | 871 Thousand USD | 17.7% |
2019 FY | 1.14 Million USD | 0.0% |
2019 Q4 | -6.02 Million USD | -791.5% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 100.0% |
2018 Q4 | -8.11 Million USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 100.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | -10.66 Million USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | -7.87 Million USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 100.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 100.0% |
2015 Q4 | -13.26 Million USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | -5.16 Million USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 100.0% |
2013 Q4 | -6.38 Million USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 100.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q4 | -7.71 Million USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 96.931% |
Allurion Technologies Inc. | 2.3 Million USD | -18000.607% |
Artivion, Inc. | 305.53 Million USD | -36.615% |
Avanos Medical, Inc. | 159.4 Million USD | -161.857% |
Butterfly Network, Inc. | 22.83 Million USD | -1727.896% |
Butterfly Network, Inc. | 22.83 Million USD | -1727.896% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 64.908% |
Boston Scientific Corporation | 8.96 Billion USD | 95.342% |
CONMED Corporation | 971.48 Million USD | 57.035% |
Edwards Lifesciences Corporation | 670 Million USD | 37.701% |
Paragon 28, Inc. | 109.79 Million USD | -280.149% |
Glaukos Corporation | 383.73 Million USD | -8.772% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -1579.948% |
Integer Holdings Corporation | 959.92 Million USD | 56.517% |
Medtronic plc | 23.87 Billion USD | 98.252% |
Myomo, Inc. | 115.16 Thousand USD | -362352.24% |
Nevro Corp. | 211.47 Million USD | -97.379% |
Owlet, Inc. | 22 Thousand USD | -1897172.727% |
Penumbra, Inc. | 220.9 Million USD | -88.947% |
Vicarious Surgical Inc. | 13.78 Million USD | -2927.929% |
Smith & Nephew plc | 2.17 Billion USD | 80.809% |
Sonendo, Inc. | 14.03 Million USD | -2873.994% |
STERIS plc | 3.12 Billion USD | 86.622% |
Stryker Corporation | 10.9 Billion USD | 96.171% |
Vapotherm, Inc. | 109.97 Million USD | -279.53% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 91.425% |